Rocket's PRV goes for $180M; Oruka targets $500M offering

April 28, 2026 10:54 AM EDT News Briefing Rock­et's PRV goes for $180M; Oru­ka tar­gets $500M of­fer­ing ENDPOINTS Rock­et sells PRV for $180M: The New Jer­sey gene ther­a­py mak­er sold the rare pe­di­atric dis­ease pri­or­i­ty re­view vouch­er to an … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER